Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI

Part 1: Welcome

 


Programme Outline
  • Part 1: WelcomeKurt Huber
  • Part 2: Pre-treatment in NSTE-ACS – dead or alive? Davide Capodanno
  • Part 3: Choice of antithrombotic agent in ACS: REACT-ing to recent trialsStefan James
  • Part 4: When to leave aspirin behind?Roxana Mehran
  • Part 5: Q&AsKurt HuberDavide CapodannoStefan JamesRoxana Mehran
Supported by an unrestricted educational grant from AstraZeneca

Part 2: Pre-treatment in NSTE-ACS – dead or alive?